SiriusPoint Ltd.
NYSE:SPNTInsurance - Reinsurance
-$0.26 today
- Market cap
- $2.98B
- Beta
- 0.62
- P/E (TTM)
- 5.3
- EPS (TTM)
- $4.28
Volume 1.13M
Average 0.73M
SPNT EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
SiriusPoint Ltd.NYSE: SPNT
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA grows, but more slowly than its trailing trend
Q2 FY2026 EBITDA of $105.4M rose 6.7% year over year, behind the +193.2% change in trailing-twelve-month EBITDA. Sequentially, it fell 25.2% from the prior quarter.
Context
- EBITDA amounted to 19.7% of revenue in FY2025, up 7.7 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 2 analysts of $373.46M (-40.9%) for the fiscal year ending Dec 2026, a slowdown from the +100.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $105.4M-25.2% QoQ
- Last fiscal yearDec 2025
- $631.9M+100.9% YoY
- LTMJun 2026
- $683.1M+193.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +6.7% | -38.1% | -44.8 pp |
| 1 year | +100.9% | -40.9% | -141.8 pp |
| 3-year CAGR | — | -14.2% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 631.9M USD
- Year-over-year change
- +100.9%
- 4-year CAGR
- +65.1%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 631.9M | +100.9% |
| FY2024 | 2024-12-31 | 314.6M | -20.1% |
| FY2023 | 2023-12-31 | 393.9M | +204.8% |
| FY2022 | 2022-12-31 | (376M) | -542.4% |
| FY2021 | 2021-12-31 | 85M | — |
EBITDA vs competitors
How SPNT compares with its peers on the latest reported figures
- SPNT's LTM Jun 2026 EBITDA of $683.1M is the 4th highest of the 11 companies compared; the peer median is $243.45M.
- Its year-over-year change of +193.2% is the 2nd highest of 11, against a peer median of -3.9%.
- EBITDA amounts to 21.0% of revenue for SPNT, versus a peer median of 27.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
MRXMarex Group plc Ordinary Shares | FY2025 | $1.21B | +39.5% | +62.0% | 33.3% |
| LTM Sep 2026 | $899.71M | +239.2% | +3.5% | 58.5% | |
| LTM Jun 2026 | $881.67M | +38.9% | +504.2% | 29.5% | |
| LTM Jun 2026 | $683.1M | +193.2% | — | 21.0% | |
| LTM Sep 2026 | $310.52M | -10.4% | +8.8% | 23.9% | |
| LTM Sep 2026 | $254.3M | -17.8% | +48.7% | 24.4% | |
| LTM Sep 2026 | $232.59M | +2.6% | +5.5% | 25.9% | |
| LTM Mar 2026 | $194.11M | +6.0% | +27.5% | 57.4% | |
| LTM Sep 2026 | $133.62M | -47.5% | -0.5% | 18.4% | |
| LTM Dec 2025 | $84.03M | -66.9% | -9.5% | 24.5% | |
| LTM Dec 2025 | -$85.17M | -57989.8% | — | 50.8% | |
| Peer median (excluding SPNT) | $243.45M | -3.9% | +8.8% | 27.7% | |
Competitors are the stored peer set for SPNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.22B | 2.17B | 2.7B | 2.61B | 3.21B |
| Cost of Revenue | 1.71B | 2.05B | 1.85B | 1.89B | 1.52B |
| Gross Profit | 510.4M | 121.3M | 848.4M | 728.4M | 1.69B |
| Gross Margin | 22.9% | 5.6% | 31.4% | 27.9% | 52.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 465.3M | 544M | 529.7M | 495.3M | 1.14B |
| Depreciation & Amortization | 5.9M | 8.1M | 11.1M | 11.9M | 10.9M |
| EBITDA | 85M | (376M) | 393.9M | 314.6M | 631.9M |
| EBITDA Margin | 3.8% | -17.3% | 14.6% | 12.0% | 19.7% |
| Operating Income | 45.1M | (422.7M) | 318.7M | 233.1M | 541.3M |
| Operating Margin | 2.0% | -19.5% | 11.8% | 8.9% | 16.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 34M | 38.6M | 64.1M | 69.6M | 79.7M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 45.1M | (422.7M) | 318.7M | 233.1M | 541.3M |
| Pre-Tax Margin | 2.0% | -19.5% | 11.8% | 8.9% | 16.9% |
| Income Tax Expense | (10.7M) | (36.7M) | (45M) | 30.7M | 81.2M |
| Net Income | 58.1M | (386.8M) | 354.8M | 199.9M | 459.6M |
| Net Margin | 2.6% | -17.8% | 13.1% | 7.6% | 14.3% |
| EPS (Basic) | 0.28 | (2.51) | 1.93 | 1.06 | 3.81 |
| EPS (Diluted) | 0.27 | (2.51) | 1.85 | 1.04 | 3.65 |
| Weighted Avg Shares | 148.67M | 160.23M | 163.34M | 166.54M | 116.51M |
| Weighted Avg Shares (Diluted) | 150.16M | 160.23M | 169.61M | 169.47M | 121.65M |
SiriusPoint Ltd.
NYSE:SPNT
Intrinsic Alpha fair value
Locked
Current Price
$25.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.